Patents by Inventor Emmanuel Letavernier

Emmanuel Letavernier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF STIRIPENTOL AND THEIR DERIVATIVES FOR DECREASING URINARY OXALATE CONCENTRATION IN AN INDIVIDUAL
    Publication number: 20210052547
    Abstract: The present invention relates to a compound of formula (I): wherein: -n is 1 or 2; Z1, Z2 and Z3, identical or different, are selected from a hydrogen atom, a halogen atom and a (C1-C6)alkyl group; and —R is an optionally substituted (C1-C6)alkyl group by one or more substituents chosen from a hydroxyl, an oxo and a thiol group; or one of its pharmaceutically acceptable salts; for use to decrease urinary oxalate concentration in an individual. The present invention further relates to a compound of formula (I) for use in the prevention and/or treatment of diseases and/or conditions related to a high urinary oxalate concentration in an individual.
    Type: Application
    Filed: February 14, 2017
    Publication date: February 25, 2021
    Applicants: Institut National de la Sante et de la Recherche Medicale (NSERM), Assistance Publique-Hopitaux de Paris, Sorbonne Universite
    Inventors: Emmanuel Letavernier, Michel Daudon
  • Methods and Pharmaceutical Compositions for Prevention of Aging-Related Lesions
    Publication number: 20150352196
    Abstract: The present invention relates to methods and compositions for prevention of aging-related lesions. More particularly, the present invention relates to a calpain inhibitor compound for use in a method for preventing aging-related lesions in a subject in need thereof.
    Type: Application
    Filed: December 18, 2013
    Publication date: December 10, 2015
    Inventors: Emmanuel Letavernier, Laurent Baud